These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17351256)

  • 1. Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
    Ilson DH; Wadleigh RG; Leichman LP; Kelsen DP
    Ann Oncol; 2007 May; 18(5):898-902. PubMed ID: 17351256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.
    Anderson SE; O'Reilly EM; Kelsen DP; Ilson DH
    Cancer Invest; 2003; 21(4):512-6. PubMed ID: 14533440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer.
    Polee MB; Eskens FA; van der Burg ME; Splinter TA; Siersema PD; Tilanus HW; Verweij J; Stoter G; van der Gaast A
    Br J Cancer; 2002 Mar; 86(5):669-73. PubMed ID: 11875723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 24-hour continuous infusion of paclitaxel in the treatment of advanced esophageal cancer].
    Wang T; Zhang SF; Wang L
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1986-8. PubMed ID: 20979865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
    Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
    Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
    J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
    Jones RJ; Hawkins RE; Eatock MM; Ferry DR; Eskens FA; Wilke H; Evans TR
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):435-41. PubMed ID: 17440725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
    Ku GY; Ilson DH; Schwartz LH; Capanu M; O'Reilly E; Shah MA; Kelsen DP; Schwartz GK
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):875-80. PubMed ID: 18270704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.
    Ajani JA; Ilson DH; Daugherty K; Pazdur R; Lynch PM; Kelsen DP
    J Natl Cancer Inst; 1994 Jul; 86(14):1086-91. PubMed ID: 7912736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.
    Seidman AD; Hudis CA; Albanell J; Tong W; Tepler I; Currie V; Moynahan ME; Theodoulou M; Gollub M; Baselga J; Norton L
    J Clin Oncol; 1998 Oct; 16(10):3353-61. PubMed ID: 9779712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with salvage weekly paclitaxel in women with advanced recurrent ovarian carcinoma.
    Dunder I; Berker B; Atabekoglu C; Bilgin T
    Eur J Gynaecol Oncol; 2005; 26(1):79-82. PubMed ID: 15755007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
    Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
    Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
    J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH; Paul DM; Hande KR; DeVore R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.
    Polee MB; Verweij J; Siersema PD; Tilanus HW; Splinter TA; Stoter G; Van der Gaast A
    Eur J Cancer; 2002 Jul; 38(11):1495-500. PubMed ID: 12110496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.